Ultimately, by assessing the landscape of patients with hematological malignancies and RCs, we propose that RC formation may be a cause and/or effect of cell cycle instability in these patients, with the direction of this relationship determined by the presence of TP53 mutations. This evidence concerns the gene TP53 and hematologic disorder.